1-11 of 11
Meghan Rourke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial of Plerixafor and Bortezomib as a Chemosensitization Strategy In Relapsed or Relapsed/Refractory Multiple Myeloma

Irene Ghobrial, MD, Abdel Kareem A. Azab, PhD, BSPharm, Jacob P. Laubach, MD, MPP, Ranjit Banwait, Meghan Rourke, Phong Quang, Nikhil C. Munshi, MD, Robert L. Schlossman, MD, Stacey Chuma, BSN, Janet Kunsman, NP, Diane Warren, Amy Sam, Eric Still, Brittany Morgan, Kenneth C. Anderson, Paul G Richardson
Journal: Blood
Blood (2010) 116 (21): 1943.
https://doi.org/10.1182/blood.V116.21.1943.1943
Published: 2010
Journal Articles

The Role of Serum Immunoglobulin Free Light Chain In Response and Progression In Waldenstrom Macroglobulinemia

Xavier Leleu, MD, PhD, Wanling Xie, MS, Meghan Rourke, Ranjit Banwait, Renee Leduc, Nitin Roper, Edie Weller, Irene Ghobrial, MD
Journal: Blood
Blood (2010) 116 (21): 3095.
https://doi.org/10.1182/blood.V116.21.3095.3095
Published: 2010
Journal Articles

Phase II Trial of Single Agent Panobinostat (LBH589) In Relapsed or Relapsed/Refractory Waldenstrom Macroglobulinemia

Irene Ghobrial, MD, Tiffany Poon, BS, Meghan Rourke, Stacey Chuma, BSN, Janet Kunsman, NP, Ranjit Banwait, Amy Sam, Diane Warren, Kenneth C. Anderson, Paul Richardson, M.D., Ph.D., Steven P. Treon, MD, PhD, Jeffrey Matous, MD
Journal: Blood
Blood (2010) 116 (21): 3952.
https://doi.org/10.1182/blood.V116.21.3952.3952
Published: 2010
Journal Articles

The Role of PET Scan Imaging In Waldenstrom Macroglobulinemia

Ranjit Banwait, Federico Campigotto, Edie Weller, Brianna Harris, Dilek Yarar, Aldo M. Roccaro, MD, PhD, Meghan Rourke, Renee Leduc, Xavier Leleu, MD, PhD, Irene M. Ghobrial, MD
Journal: Blood
Blood (2010) 116 (21): 4153.
https://doi.org/10.1182/blood.V116.21.4153.4153
Published: 2010
Journal Articles

Final Results of the Phase I/II Trial of Weekly Bortezomib In Combination with Temsirolimus (CCI-779) In Relapsed or Relapsed/Refractory Multiple Myeloma Specifically In Patients Refractory to Bortezomib

Irene M. Ghobrial, MD, Edie Weller, Ravi Vij, MBBS, MD, Nikhil C. Munshi, MD, Ranjit Banwait, Meghan Rourke, Robert L. Schlossman, MD, Jacob P. Laubach, MD, Andrzej J Jakubowiak, MD, PhD, Renee Leduc, Stacey Chuma, BSN, Janet Kunsman, NP, Akari M. Dollard, Diane Warren, Brianna Harris, Tiffany Poon, BS, Amy Sam, Scott J Rodig, Kenneth C. Anderson, Paul G Richardson
Journal: Blood
Blood (2010) 116 (21): 990.
https://doi.org/10.1182/blood.V116.21.990.990
Published: 2010
Journal Articles

Phase II Trial of Weekly Bortezomib in Combination with CCI-779 (temsirolimus) in Relapsed or Relapsed/Refractory Multiple Myeloma.

Irene M. Ghobrial, M.D., Ravi Vij, MD, Nikhil C. Munshi, Robert L Schlossman, M.D., Ph.D., Jacob Laubach, Erica L. Campagnaro, MD, Renee Leduc, Meghan Rourke, Stacey Chuma, Janet Kunsman, NP, Akari M. Dollard, Diane Warren, Brianna Harris, Amy Sam, Kenneth C. Anderson, MD, Paul Richardson, M.D., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 748.
https://doi.org/10.1182/blood.V114.22.748.748
Published: 2009
Journal Articles

Phase II Trial of Weekly Bortezomib in Combination with Rituximab in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia.

Irene M. Ghobrial, M.D., Fangxin Hong, PhD, Swaminathan Padmanabhan, MD, Ashraf Z. Badros, MD, Meghan Rourke, Renee Leduc, Stacey Chuma, Janet Kunsman, NP, Diane Warren, Brianna Harris, Amy Sam, Kenneth C. Anderson, MD, Paul Richardson, M.D., Ph.D., Steven Treon, MD, PhD, Edie Weller, PhD, Jeffrey Matous
Journal: Blood
Blood (2009) 114 (22): 2727.
https://doi.org/10.1182/blood.V114.22.2727.2727
Published: 2009
Journal Articles

Serum Immunoglobulin Free Light Chain (sFLC) Measurement as a New Marker of Response to Therapy and Survival in Waldenstrom Macroglobulinemia (WM).

Xavier Leleu, Renee Leduc, Meghan Rourke, Stacey Chuma, Amy Sam, Brianna Harris, Janet Kunsman, NP, Irene M. Ghobrial, M.D.
Journal: Blood
Blood (2009) 114 (22): 3952.
https://doi.org/10.1182/blood.V114.22.3952.3952
Published: 2009
Journal Articles

Phase II Trial of Weekly Bortezomib in Combination with Rituximab in Untreated Patients with Waldenstrom's Macroglobulinemia.

Irene M. Ghobrial, M.D., Swaminathan Padmanabhan, Ashraf Z. Badros, MD, Renee Leduc, Meghan Rourke, Stacey Chuma, Janet Kunsman, NP, Diane Warren, Brianna Harris, Amy Sam, Kenneth C. Anderson, MD, Paul Richardson, M.D., Ph.D., Steven Treon, MD, PhD, Jeffrey Matous
Journal: Blood
Blood (2009) 114 (22): 3752.
https://doi.org/10.1182/blood.V114.22.3752.3752
Published: 2009
Journal Articles

A Phase II Trial of the Oral mTOR Inhibitor Everolimus (RAD001) in Relapsed or Refractory Waldenstrom's Macroglobulinemia.

Irene M Ghobrial, M.D., Morie A Gertz, MD, Betsy LaPlant, John Camoriano, MD, Suzanne R. Hayman, MD, Martha Q. Lacy, MD, Stacey Chuma, Patricia Sheehy, NP, Brianna Harris, Renee Leduc, Meghan Rourke, Stephen M Ansell, Daniel J DeAngelo, MD, PhD, Angela Dispenzieri, Leif Bergsagel, Craig B. Reeder, MD, Kenneth C. Anderson, MD, Paul Richardson, M.D., Ph.D., Steven Treon, MD, PhD, Thomas E Witzig, MD
Journal: Blood
Blood (2009) 114 (22): 587.
https://doi.org/10.1182/blood.V114.22.587.587
Published: 2009
Journal Articles

PET/CT a New Marker of Response in Waldenstrom Macroglobulinemia (WM).

Xavier Leleu, Renee Leduc, Meghan Rourke, Brianna Harris, Aldo M. Roccaro, MD, PhD, Dilek Yarar, Jonathan Farag, Irene M. Ghobrial, M.D.
Journal: Blood
Blood (2009) 114 (22): 1937.
https://doi.org/10.1182/blood.V114.22.1937.1937
Published: 2009